Document:

EX-10.2

 Exhibit 10.2 
 EXECUTION VERSION 
 TRANSITION AND SERVICES AGREEMENT

 This TRANSITION AND SERVICES AGREEMENT (this “Agreement”), delivered this 15th day of
May 2013 (the “Delivery Date”), confirms the following understandings and agreements between RenaissanceRe Holdings Ltd. (the “Company”) and Neill A. Currie (“you”). All capitalized terms
used, but not defined, herein shall have the meanings ascribed to them in your further amended and restated employment agreement with the Company dated as of February 19, 2009, as amended January 8, 2010, February 19, 2013 and
April 5, 2013 (as amended, your “Employment Agreement”). 
 W I T N
E S S E T H : 
 WHEREAS, you currently serve as Chief Executive Officer of the
Company; 
 WHEREAS, you and the Company are parties to your Employment Agreement, which sets forth the terms and
conditions of your employment with the Company; 
 WHEREAS, you and the Company now desire to enter into a mutually
satisfactory arrangement concerning, among other things, succession planning, the terms of your service during a transition period, your continued employment through the expiration of the Term of Employment, and other matters related thereto;

 WHEREAS, subject to the terms and conditions contained herein, you and the Company mutually agree to embody in this
Agreement the terms and conditions applicable to your continued employment with the Company; and 
 WHEREAS, this
Agreement contains a mutual release of claims and constitutes the mutually agreeable mutual general release of claims contemplated by Section 8(i) of your Employment Agreement, and by delivery hereof, the Company hereby notifies you, and you
hereby acknowledge your understanding, that your execution and non-revocation of this Agreement and the Second General Release (as defined below), are required for you to receive any of the payments and benefits set forth in Section 8(g) of
your Employment Agreement (other than the Accrued Obligations). 
 NOW, THEREFORE, in consideration of the
promises and mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are mutually acknowledged, you and the Company hereby agree as follows: 

Section 1. Termination of Employment. 
 (a) Termination Date. You hereby acknowledge and agree that the termination of your employment with the Company and its Affiliates (collectively, with the Company, the “Company
Group”) pursuant to Section 8(g) of your Employment Agreement, and from any other position you held as an officer, director, committee member, or other service provider of any member of the Company Group, and the expiration of the Term
of Employment, will become effective as of the close of business on February 22, 2014, or if earlier, the date of your death, a termination due to your Disability, a termination by the Company for Cause, or a

 
termination by you for any reason (in any such earlier case, an “Early Termination”), and the earlier of February 22, 2014 and the date of any Early Termination shall be
referred to herein as the “Termination Date.” Except as otherwise expressly set forth herein, you shall not represent yourself after the Termination Date as being an employee, officer, director, agent, or representative of
the Company or any other member of the Company Group for any purpose. Notwithstanding anything in your Employment Agreement to the contrary, (x) the term “Good Reason” shall hereafter mean solely, without your consent, any
breach by the Company of any material provision of this Agreement, and (y) the term “Cause” shall hereafter have the meaning set forth in your Employment Agreement, disregarding clause (ii) thereof. Except as otherwise
provided in your Employment Agreement, the Termination Date shall be the termination date of your employment for purposes of participation in and coverage under all benefit plans and programs sponsored by or through the Company or any other member
of the Company Group. Except as otherwise explicitly set forth herein, the terms and conditions set forth in your Employment Agreement shall continue to govern your employment with the Company. In the event that any terms of this Agreement might be
deemed, at any time, to conflict with the terms of your Employment Agreement or would result in a duplication of benefits, the terms of this Agreement shall exclusively govern. 

(b) Resignation of Officer Positions. Notwithstanding anything in Section 1(a) above to the contrary, on July 1, 2013
you shall cease serving as Chief Executive Officer of the Company and as a member of the board of directors of the Company (the “Board”) and from any other executive officer and director positions that you hold within the Company
Group as of such date. You and the Company agree that your transition is taking place pursuant to and shall be governed by Section 8(g) of your Employment Agreement except to the extent explicitly provided herein. You shall continue to be an
employee of the Company through the end of the Term of Employment, and such resignations shall in no respect be considered a termination of employment for any purpose under your Employment Agreement. During the period following July 1, 2013 and
ending on the last day of the Term of Employment (subject to any Early Termination), you shall continue to be employed in a non-executive capacity and shall have the title of Senior Advisor. 

Section 2. Compensation and Benefits. 
 (a) General. From the date on which this Agreement is executed and through the remainder of the Term of Employment, you shall continue to receive all compensation and benefits set forth in your
Employment Agreement, remain eligible to participate in the health insurance and other benefit plans of the Company in which you are currently eligible to participate, and continue to receive the perquisites and other personal benefits currently
provided to you, subject in all cases to the discretion of the Company to amend or terminate any or all of such plans or arrangements at any time and from time to time in accordance with the terms of your Employment Agreement; provided,
however, that you hereby acknowledge and agree that you shall not be entitled to receive any new grants of Awards on or after the date hereof. 
 (b) Continued Vesting. During the Term of Employment, unvested Awards shall continue to vest according to their terms and any applicable provisions contained in your Employment Agreement.

  
 -2-

 Section 3. Opportunity for Review; Acceptance. 

You shall have from the Delivery Date until June 5, 2013 (the “Review Period”), to review
and consider this Agreement. To accept this Agreement and the terms and conditions contained herein, you must execute and date this Agreement where indicated below and return the executed copy of this Agreement to the Company prior to the expiration
of the Review Period, to the attention of the Company’s General Counsel. Notwithstanding anything contained herein to the contrary, this Agreement will not become effective or enforceable for a period of seven (7) calendar days following
the date of its execution and delivery to the Company (the “Revocation Period”), during which time you may further review and consider this Agreement and revoke your acceptance of this Agreement by notifying the Company’s
General Counsel in writing. To be effective, such revocation must be received no later than 5:00 p.m., Atlantic Time, on the last day of the Revocation Period. Provided that this Agreement is executed and you have not timely revoked it, the eighth
(8th) day following the date on which this Agreement
is executed and delivered to the Company shall be its effective date (the “Effective Date”). In the event of your failure to execute and deliver this Agreement prior to the expiration of the Review Period, or your subsequent
revocation of this Agreement during the Revocation Period, this Agreement will be null and void and of no effect, the Company will have no obligations hereunder, and you shall not be entitled to any payments or benefits under your Employment
Agreement that are conditioned upon the execution of a release of claims (which for purposes of clarification shall include all payments and benefits otherwise owing to you thereunder following the Termination Date, other than Accrued Obligations).

 Section 4. Mutual Release and Waiver of Claims. 

(a) Definition. As used in this Agreement, the term “claims” will include all claims, covenants, warranties,
promises, undertakings, actions, suits, causes of action, obligations, debts, accounts, attorneys’ fees, judgments, losses, and liabilities, of whatsoever kind or nature, in law, equity, or otherwise. 

(b) Your Release and Waiver of Claims. 
 (i) For and in consideration of the payments and benefits set forth in this Agreement and other good and valuable consideration, including the Company’s release and waiver of claims described in
Section 4(c) below, you, for and on behalf of yourself and your heirs, administrators, executors, and assigns, effective as of the date of your execution of this Agreement, do fully and forever release, remise, and discharge the Company, and
all other members of the Company Group, together with their respective officers, directors, partners, shareholders, employees, and agents (collectively, and with the Company and the Company Group, the “Company Parties”), from
any and all claims whatsoever up to and including the date of your execution of this Agreement that you had, may have had, or now have against any of the Company Parties, for or by reason of any matter, cause, or thing whatsoever arising out of or
attributable to your employment or the termination of your employment with the Company, whether for tort, breach of express or implied employment contract, intentional infliction of emotional distress, wrongful termination, unjust dismissal,
defamation, libel, or slander, or under any Bermuda, United States federal, state, or local law or regulation dealing with discrimination based on age, race, sex, national origin, handicap, religion, disability, or

  
 -3-

 
sexual orientation. This release of claims includes, but is not limited to, all claims arising under any applicable Bermuda law or regulation or under the following United States statutes: the
Age Discrimination in Employment Act (the “ADEA”), Title VII of the Civil Rights Act, the Americans with Disabilities Act, the Civil Rights Act of 1991, the Family Medical Leave Act, and the Equal Pay Act, each as may be
amended from time to time, and all other United States federal, state, and local laws, the common law, and any other purported restriction on an employer’s right to terminate the employment of an employee. The parties intend the release
contained herein to be a general release of any and all claims to the fullest extent permissible by law. 
 (ii)
You acknowledge and agree that as of the date you execute this Agreement, you have no knowledge of any facts or circumstances that give rise or could give rise to any claims under any of the laws listed in the preceding paragraph. 

(iii) By executing this Agreement, you specifically release all claims relating to your employment and its termination
under the ADEA, a United States federal statute that, among other things, prohibits discrimination on the basis of age in employment and employee benefit plans. 
 (iv) Notwithstanding the foregoing, nothing in this Agreement shall be a waiver of your rights with respect to payment of amounts and other benefits under this Agreement or any claims that cannot be
waived by law. 
 (c) The Company’s Release and Waiver of Claims. For and in consideration of your continuing
obligations to the Company pursuant to this Agreement and your Employment Agreement as well as your waiver and release of claims described in Section 4(b) above, the Company, on behalf of itself and the Company Parties, hereby releases and
forever discharges you from any and all claims whatsoever up to the Delivery Date that it had, may have had, or now has for or by reason of any claim arising out of or attributable to your employment or, to the maximum extent permitted by law,
service as a member of the Board or the termination of your employment or, to the maximum extent permitted by law, such Board service with the Company, or pursuant to any Bermuda, United States federal, state, or local law or regulation (excluding
in all events any claims any of the Company Parties may have in the future for a breach of this Agreement or Employment Agreement or based on any criminal actions by you). 
 (d) Second General Release. For and in consideration of the payments and benefits set forth in this Agreement, you agree to execute the release and waiver of claims set forth on Exhibit A
hereto and made a part hereof (the “Second General Release”). You hereby agree that the Second General Release may not be executed by you earlier than February 22, 2014 (or in the case of an Early Termination due to your
death or Disability, the date of such Early Termination), or later than March 15, 2014, and in the event you do not timely execute the Second General Release, or you revoke the Second General Release pursuant to its terms, you shall not be
entitled to any further payments or benefits (other than Accrued Obligations) from any member of the Company Group, including without limitation any compensation and benefits set forth in Sections 7(a) and 7(b) of this Agreement or the
Company’s agreement to waive and release you from claims as set forth in the Second General Release. For the avoidance of doubt, in the event of an Early Termination due to your death or Disability, your obligations herein and in Exhibit
A hereto to execute and not revoke the Second General Release may be satisfied on your behalf by your estate or a person having legal power of attorney over your affairs. 

  
 -4-

 Section 5. No Suit. 

Each of you and the Company represents and warrants that you and it, respectively, have not previously filed, and to the maximum extent
permitted by law agree not to file, a claim against the other party (which, for purposes of this Section 5, includes the Company Parties), respectively, regarding any of the claims respectively released herein. If, notwithstanding this
representation and warranty, either you or the Company has filed or files such a claim, the filing party agrees to cause such claim to be dismissed with prejudice and shall pay any and all costs required in obtaining dismissal of such claim,
including without limitation the attorneys’ fees and expenses of any of the parties against whom such a claim has been filed. You acknowledge that this paragraph shall not apply, however, to any non-waivable right to file a charge with the
United States Equal Employment Opportunity Commission (the “EEOC”), provided, however, that if the EEOC were to pursue any claims relating to your employment with the Company, you agree that you shall not be entitled to
recover any monetary damages or any other remedies or benefits as a result and that this Agreement and the payments and benefits described in Section 8(g) of your Employment Agreement will control as the exclusive remedy and full settlement of
all such claims by you. 
 Section 6. Knowing and Voluntary Waiver. You expressly acknowledge and agree that you:

 (a) Are able to read the language, and understand the meaning and effect, of this Agreement; 

(b) Have no physical or mental impairment of any kind that has interfered with your ability to read or understand the
meaning of this Agreement or its terms, and that you are not acting under the influence of any medication, drug, or chemical of any type in entering into this Agreement; 

(c) Are specifically agreeing to the terms of the release contained in this Agreement because the Company has agreed to
provide you with the payments and benefits described in Section 8(g) of your Employment Agreement (other than the Accrued Obligations) and because of the Company’s agreement to waive and release you from claims as set forth in
Section 4(c) above, which the Company has agreed to provide because of your agreement to accept it in full settlement of all possible claims you might have or ever had that are released hereunder, and because of your execution of this
Agreement; 
 (d) Acknowledge that but for your execution of this Agreement, you would not be entitled to the
payments or benefits described in Section 8(g) of your Employment Agreement (other than the Accrued Obligations) or the Company’s waiver and release of claims described in Section 4(c) above; 

  
 -5-

 (e) Understand that, by entering into this Agreement, you do not waive
rights or claims under the ADEA that may arise after the date you execute this Agreement; 
 (f) Had or could
have had the entire Review Period in which to review and consider this Agreement, and that if you execute this Agreement prior to the expiration of the Review Period, you have voluntarily and knowingly waived the remainder of the Review Period;

 (g) Have or had the entire Revocation Period in which to revoke your execution of this Agreement, and that if
you do not revoke such execution prior to the Effective Date, you have knowingly and voluntarily agreed to this Agreement’s becoming effective; 
 (h) Were advised to consult with your attorney regarding the terms and effect of this Agreement; and 
 (i) Have signed this Agreement knowingly and voluntarily. 
 Section 7.
Separation Payments. 
 (a) General. Following your Termination Date, in consideration for and subject to your
execution and non-revocation of this Agreement and the Second General Release, you shall be entitled to (i) the payments and benefits described in Section 8(g) of your Employment Agreement in accordance with the terms thereof;
provided, however, (A) the Accrued Obligations (including your rights to indemnification pursuant to Section 12 of your Employment Agreement, which shall survive the Termination Date) shall be provided to you pursuant to your
Employment Agreement in all events regardless of whether this Agreement or the Second General Release is executed or becomes effective, (B) the pro rata Annual Bonus you are eligible to receive, as contemplated by Section 8(d)(v) of your
Employment Agreement, shall be determined based on your target Annual Bonus for 2013 of $1,742,070, and, in the event of an Early Termination due to your death or Disability, you shall be deemed to have terminated employment on February 22,
2014, for purposes of determining the amount of such pro rata Annual Bonus, (C) the Annual Bonus, as contemplated in Section 8(d)(iv) of your Employment Agreement, shall be determined as the greater of your target Annual Bonus for 2014 and
the actual Annual Bonus paid to you during 2013 in respect of the 2012 year pursuant to the Company’s customary practices, (D) the Annual Bonus you are eligible to receive in 2014 in respect of 2013 performance, as contemplated by
Section 8(d)(ii) of your Employment Agreement, shall be an amount equal to your target Annual Bonus for 2013 of $1,742,070 and shall be payable to you within ten (10) business days following the Termination Date, (ii) reimbursement
for reasonable repatriation costs to the United States for you, your family, and your personal belongings, (iii) at your election, you may make use of the personal tax services made available by the Company for the preparation of your 2014 tax
return, subject to the Company’s current policies, and (iv) continue participating in the Company’s health plans at your own expense as described in Section 7(b) below. 

(b) Health Coverage. Subject to the provisions of Section 7(a) above requiring your Second General Release that is not
revoked, following the period of continued 

  
 -6-

 
health benefits provided by Section 8(d)(vi) of your Employment Agreement, you shall be entitled to continue participating in the Company’s (or, in the discretion of the Company, an
Affiliate’s) health plans (as in effect from time to time) in respect of you and your covered dependents, at your sole expense and subject to availability of coverage in accordance with the policies of the insurance provider, until the earliest
to occur of (i) the date on which you attain age 65 or if earlier, in respect of any covered dependent, the date on which such person attains age 65; provided, that, in the event that a covered dependent turns 65, your ability to
maintain coverage under the Company’s or Affiliate’s health plans shall only terminate with respect to such covered dependent, (ii) the date on which you (or a covered dependent, as applicable) become eligible to receive coverage
under any other health plan provided by a new employer; provided, that, in the event that a covered dependent receives coverage under any other such health plan, your ability to maintain coverage under the Company’s or Affiliate’s
health plans shall only terminate with respect to such covered dependent, and (iii) the date on which you breach any of the terms of this Agreement or your Employment Agreement. 

(c) No Further Entitlements. You acknowledge and agree that the payments and other benefits provided to you hereunder in
connection with your continued employment through the expiration of the Term of Employment and your termination of employment are in full discharge of any and all liabilities and obligations of the Company or any other member of the Company Group to
you, monetarily or with respect to employee benefits or otherwise, including but not limited to any and all obligations arising under any alleged written or oral employment agreement, arrangement, policy, plan, or procedure of the Company or any
other member of the Company Group or any alleged understanding or arrangement between you and the Company or any other member of the Company Group. Further, you acknowledge and agree that in no event shall the Company have any further obligations
under your Employment Agreement other than as expressly set forth herein or therein. 
 (d) Taxes. The payments
referenced in this Section 7 shall be subject to reduction for tax and other withholding obligations as described in Section 13 of your Employment Agreement. 
 (e) Continuing Obligations. Without limiting anything herein or in your Employment Agreement, your obligations to the Company pursuant to Sections 8(j), 9, 10, 12, and 13 of your Employment
Agreement shall survive the Termination Date according to their terms, as will Section 15 of your Employment Agreement; provided, that for purposes of Sections 9 and 10 of your Employment Agreement, the Restricted Period shall
continue through the 18-month anniversary of the earlier to occur of an Early Termination and the Termination Date. 
 (f)
Early Termination. Notwithstanding anything in this Agreement or your Employment Agreement to the contrary, in the event of an Early Termination by the Company for Cause or by you other than for Good Reason, death or Disability, then
following such Early Termination you shall not be entitled to any further payments or benefits (other than Accrued Obligations) from any member of the Company Group, including without limitation any further compensation and benefits in Sections 7(a)
and 7(b). 

  
 -7-

 Section 8. Successors and Assigns. 

The provisions hereof shall, with respect to you, inure to the benefit of your heirs, executors, administrators, legal personal
representatives, and assigns and shall be binding upon your heirs, executors, administrators, legal personal representatives, and assigns, and with respect to the Company Parties, inure to the benefit of and be enforceable by, and may be assigned by
the Company Parties to, any purchaser of all or substantially all of their respective business or assets or any successor to the Company Parties (whether direct or indirect, by purchase, merger, consolidation, or otherwise), and where applicable,
their heirs, executors, administrators, legal personal representatives, and assigns. 
 Section 9. Severability.

 If any provision of this Agreement shall be held by any court of competent jurisdiction to be illegal, void, or unenforceable,
such provision shall be of no force or effect. The illegality or unenforceability of such provision, however, shall have no effect upon and shall not impair the enforceability of any other provision of this Agreement. 

Section 10. Non-Disparagement. 
 You agree that you will make no disparaging or defamatory comments regarding any of the Company Parties in any respect or make any comments concerning any aspect of your relationship with any of the
Company Parties or the conduct or events that precipitated your termination of employment from any member of the Company Group. Similarly, the Company shall make no disparaging or defamatory comments regarding you in any respect or make any comments
concerning any aspect of your relationship with any member of the Company Group or the conduct or events that precipitated your termination of employment from any member of the Company Group (it being understood that the foregoing shall not prevent
any representative of the Company Group from verifying your employment to any potential subsequent employer); provided, for such purpose, the “Company” shall mean only its executive officers and members of the Board or any public statement
made in the name of the Company. The obligations of you and the Company under this Section 10 shall not apply to disclosures required by applicable law, regulation, or order of a court or governmental agency. 

Section 11. Non-Admission. 
 Nothing contained in this Agreement will be deemed or construed as an admission of wrongdoing or liability on the part of you or any Company Party. 

Section 12. Entire Agreement. 
 This Agreement constitutes the entire understanding and agreement of the parties hereto regarding your termination of employment. This Agreement supersedes all prior negotiations, discussions,
correspondence, communications, understandings, and agreements between the parties relating to the subject matter of this Agreement. 

  
 -8-

 Section 13. Governing Law; Jurisdiction. 

THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH BERMUDA LAW (WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES
THEREOF) APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT COUNTRY. EACH PARTY TO THIS AGREEMENT HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS AGREEMENT.

 *        *        * 

  
 -9-

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date
set forth below. 
  

			
	RENAISSANCERE HOLDINGS LTD.
		
	By:	 	 /s/ Peter C. Durhager

	Name:	 	Peter C. Durhager
	Title:	 	 Executive Vice President and

Chief Administrative Officer

		
		 	 /s/ Neill A. Currie
 Neill A. Currie

		 	Dated: May 15, 2013

  
 -10-

 SECOND GENERAL RELEASE 

Section 1. Opportunity for Review; Acceptance. 

You shall have from the Delivery Date until March 15, 2014 (the “Second General Release Review
Period”), to review and consider this Second General Release. To accept this Second General Release and the terms and conditions contained herein, you must execute and date this Second General Release where indicated below and return the
executed copy of the Second General Release to the Company prior to the expiration of the Second General Release Review Period, but no earlier than February 22, 2014 (or in the case of an Early Termination due to your death or Disability, the
date of such Early Termination), to the attention of the Company’s General Counsel. Notwithstanding anything contained herein to the contrary, this Second General Release will not become effective or enforceable for a period of seven
(7) calendar days following the date of its execution and delivery to the Company (the “Second General Release Revocation Period”), during which time you may further review and consider the Second General Release and
revoke your acceptance of this Second General Release by notifying the Company’s General Counsel in writing. To be effective, such revocation must be received no later than 5:00 p.m., Atlantic Time, on the last day of the Second General Release
Revocation Period. Provided that the Second General Release is executed and you have not timely revoked it, the eighth
(8th) day following the date on which the Second
General Release is executed and delivered to the Company shall be its effective date (the “Second General Release Effective Date”). In the event of your failure to timely execute and deliver this Second General Release or your
subsequent revocation of this Second General Release during the Second General Release Revocation Period, this Second General Release will be null and void and of no effect, the Company will have no further obligations under the Agreement, and you
shall not be entitled to any payments or benefits under your Employment Agreement that are conditioned upon the execution of a release of claims (which for purposes of clarification shall be any and all payments and benefits otherwise owing to you
thereunder following the Termination Date, other than Accrued Obligations). 
 Section 2. Mutual Release and Waiver of
Claims. 
 (a) Definition. As used in this Second General Release, the term “claims” will include all
claims, covenants, warranties, promises, undertakings, actions, suits, causes of action, obligations, debts, accounts, attorneys’ fees, judgments, losses, and liabilities, of whatsoever kind or nature, in law, equity, or otherwise. 

(b) Your Release and Waiver of Claims. 
 (i) For and in consideration of the payments and benefits set forth in the Agreement and other good and valuable consideration, including the Company’s release and waiver of claims described in
Section 2(c) below, you, for and on behalf of yourself and your heirs, administrators, executors, and assigns, effective as of the date of your execution of this Second General Release, do fully and forever release, remise, and discharge the
Company Parties from any and all claims whatsoever up to and including the date of your execution of this Second General Release that you had, may have had, or now have against any of the Company Parties, for or by reason of any matter, cause, or

  
 -A1-

 
thing whatsoever arising out of or attributable to your employment or the termination of your employment with the Company, whether for tort, breach of express or implied employment contract,
intentional infliction of emotional distress, wrongful termination, unjust dismissal, defamation, libel, or slander, or under any Bermuda, United States federal, state, or local law or regulation dealing with discrimination based on age, race, sex,
national origin, handicap, religion, disability, or sexual orientation. This release of claims includes, but is not limited to, all claims arising under any applicable Bermuda law or regulation or under the following United States statutes: the
ADEA, Title VII of the Civil Rights Act, the Americans with Disabilities Act, the Civil Rights Act of 1991, the Family Medical Leave Act, and the Equal Pay Act, each as may be amended from time to time, and all other United States federal, state,
and local laws, the common law, and any other purported restriction on an employer’s right to terminate the employment of an employee. The parties intend the release contained herein to be a general release of any and all claims to the fullest
extent permissible by law. 
 (ii) You acknowledge and agree that as of the date you execute this Second General
Release, you have no knowledge of any facts or circumstances that give rise or could give rise to any claims under any of the laws listed in the preceding paragraph. 

(iii) By executing this Second General Release, you specifically release all claims relating to your employment and its
termination under the ADEA, a United States federal statute that, among other things, prohibits discrimination on the basis of age in employment and employee benefit plans. 

(iv) Notwithstanding the foregoing, nothing in this Second General Release shall be a waiver of your rights with respect
to payment of amounts and other benefits under the Agreement or any claims that cannot be waived by law. Furthermore, nothing under this Section 2(b) is a waiver of any claim under Section 12 of the Employment Agreement and the provisions
of Section 12 shall survive the Termination Date. 
 (c) The Company’s Release and Waiver of Claims. For and in
consideration of your continuing obligations to the Company pursuant to this Second General Release and your Employment Agreement as well as your waiver and release of claims described in Section 4(b) above, the Company, on behalf of itself and
the Company Parties, hereby releases and forever discharges you from any and all claims whatsoever up to the Second General Release Effective Date that it had, may have had, or now has for or by reason of any claim arising out of or attributable to
your employment or, to the maximum extent permitted by law, service as a member of its Board of Directors or the termination of your employment or, to the maximum extent permitted by law, such Board service with the Company, or pursuant to any
Bermuda, United States federal, state, or local law or regulation(excluding in all events any claims any of the Company Parties may have in the future for a breach of this Agreement, this Second General Release or Employment Agreement or based on
any criminal actions by you). 

  
 -A2-

 Section 3. No Suit. 

Each of you and the Company represents and warrants that you and it, respectively, have not previously filed, and to the maximum extent
permitted by law agree not to file, a claim against the other party (which, for purposes of this Section 3, includes the Company Parties), respectively, regarding any of the claims respectively released herein. If, notwithstanding this
representation and warranty, either you or the Company has filed or files such a claim, the filing party agrees to cause such claim to be dismissed with prejudice and shall pay any and all costs required in obtaining dismissal of such claim,
including without limitation the attorneys’ fees and expenses of any of the parties against whom such a claim has been filed. You acknowledge that this paragraph shall not apply, however, to any non-waivable right to file a charge with the
United States Equal Employment Opportunity Commission (the “EEOC”), provided, however, that if the EEOC were to pursue any claims relating to your employment with the Company, you agree that you shall not be entitled to
recover any monetary damages or any other remedies or benefits as a result and that this Agreement and the payments and benefits described in Section 8(g) of your Employment Agreement will control as the exclusive remedy and full settlement of
all such claims by you. 
 Section 4. Knowing and Voluntary Waiver. You expressly acknowledge and agree that you:

 (a) Are able to read the language, and understand the meaning and effect, of this Second General Release;

 (b) Have no physical or mental impairment of any kind that has interfered with your ability to read or
understand the meaning of this Second General Release or its terms, and that you are not acting under the influence of any medication, drug, or chemical of any type in entering into this Second General Release; 

(c) Are specifically agreeing to the terms of this Second General Release because the Company has agreed to provide you
the payments and benefits described in the Agreement and because of the Company’s agreement to waive and release you from claims as set forth in Section 2(c) above, which the Company has agreed to provide because of your agreement to
accept it in full settlement of all possible claims you might have or ever had that are released hereunder, and because of your execution of this Second General Release; 

(d) Acknowledge that but for your execution of this Second General Release, you would not be entitled to the payments or
benefits described in the Agreement or the Company’s waiver and release of claims described in Section 2(c) above; 
 (e) Understand that, by entering into this Second General Release, you do not waive rights or claims under the ADEA that may arise after the date you execute this Second General Release; 

(f) Had or could have had the entire Second General Release Review Period in which to review and consider this Second
General Release, and that if you execute this Second General Release prior to the expiration of the Second General Release Review Period, you have voluntarily and knowingly waived the remainder of the Second General Release Review Period;

  
 -A3-

 (g) Have or had the entire Second General Release Revocation Period in which
to revoke your execution of this Second General Release, and that if you do not revoke such execution prior to the Second General Release Effective Date, you have knowingly and voluntarily agreed to this Second General Release’s becoming
effective; 
 (h) Were advised to consult with your attorney regarding the terms and effect of this Second
General Release; and 
 (i) Have signed this Second General Release knowingly and voluntarily. 

*      *      * 

  
 -A4-

 IN WITNESS WHEREOF, the parties hereto have executed this Second General Release as
of the date set forth below. 
  

			
	RENAISSANCERE HOLDINGS LTD.
		
	By:	 	  

	Name:	 	
	Title:	 	
		
		 	  

		 	Neill A. Currie
		 	Dated:

  
 -A5-EX-4.1

 Exhibit 4.1 
 EXECUTION COPY 
 COVIDIEN INTERNATIONAL FINANCE S.A., 

as Issuer 
 AND

 COVIDIEN PUBLIC LIMITED COMPANY AND COVIDIEN LTD., 
 as Guarantors 
 AND 

DEUTSCHE BANK TRUST 
 COMPANY AMERICAS, 
 as Trustee 

EIGHTH SUPPLEMENTAL INDENTURE 
 Dated as of May 16, 2013 
 $750,000,000 of 2.950% Senior Notes due 2023

 THIS EIGHTH SUPPLEMENTAL INDENTURE is dated as of May 16, 2013 among COVIDIEN
INTERNATIONAL FINANCE S.A., a Luxembourg company (the “Company”), COVIDIEN PUBLIC LIMITED COMPANY, an Irish company (“Covidien plc”), and COVIDIEN LTD., a Bermuda company (“Covidien Ltd.”, and
together with Covidien plc, the “Guarantors”), and DEUTSCHE BANK TRUST COMPANY AMERICAS, a New York banking corporation (the “Trustee”). 
 RECITALS 
 A. WHEREAS, the Company, the Guarantors and the Trustee executed and
delivered an Indenture, dated as of October 22, 2007 (as supplemented prior to the date hereof, the “Base Indenture,” and as further supplemented by this Eighth Supplemental Indenture, the “Indenture”), to
provide for the issuance by the Company from time to time of unsubordinated debt securities evidencing its unsecured indebtedness. 
 B. WHEREAS, pursuant to the Base Indenture, the Company desires to establish a new series of its debt securities, to be known as its “2.950% Senior Notes due 2023” (the “Offered
Securities”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Eighth Supplemental Indenture; 

C. WHEREAS, pursuant to a resolution of its board of directors, the Company has authorized the issuance of the Offered Securities.

 D. WHEREAS, the entry into this Eighth Supplemental Indenture by the parties hereto is in all respects authorized by the
provisions of the Base Indenture. 
 E. WHEREAS, the Company and the Guarantors desire to enter into this Eighth Supplemental
Indenture pursuant to Section 9.01(i) of the Base Indenture to establish the terms of the Offered Securities in accordance with Section 2.01 of the Base Indenture and to establish the form of the Offered Securities in accordance with
Section 2.02 of the Base Indenture. 
 F. WHEREAS all things necessary to make this Eighth Supplemental Indenture a valid
indenture and agreement according to its terms have been done. 
 NOW, THEREFORE, for and in consideration of the foregoing
premises, the Company, the Guarantors and the Trustee mutually covenant and agree for the equal and proportionate benefit of the respective holders from time to time of the Offered Securities as follows: 

ARTICLE I 
 Section 1.1.
Terms of Offered Securities. 
 The following terms relate to the Offered Securities: 

(1) The Offered Securities constitute a new series of securities having the title “2.950% Senior Notes due 2023”. 

(2) The initial aggregate principal amount of the Offered Securities that may be authenticated and delivered under the Base Indenture
(except for Offered Securities authenticated and delivered upon transfer of, or in exchange for, or in lieu of, other Offered Securities pursuant to Section 2.05, 2.06, 2.07, 2.11, or 3.03 of the Base Indenture) is $750,000,000. 

  
 2 

 (3) The entire Outstanding principal amount of the Offered Securities shall be payable on
June 15, 2023. 
 (4) The rate at which the Offered Securities shall bear interest shall be 2.950% per year. The date
from which interest shall accrue on the Offered Securities shall be May 16, 2013, or the most recent Interest Payment Date for the Offered Securities to which interest has been paid or provided for. The Interest Payment Dates for the Offered
Securities shall be June 15 and December 15 of each year, beginning December 15, 2013. Interest shall be payable on each Interest Payment Date for the Offered Securities to the holders of record at the close of business on the
June 1 and December 1 prior to each Interest Payment Date for the Offered Securities. 
 The basis upon which interest
shall be calculated shall be that of a 360-day year consisting of twelve 30-day months. 
 (5) The Offered Securities shall be
issuable in whole in the form of one or more registered Global Securities, and the Depository for such Global Securities shall be The Depository Trust Company, New York, New York. The Offered Securities shall be substantially in the form attached
hereto as Exhibit A, the terms of which are herein incorporated by reference. The Offered Securities shall be issuable in denominations of $2,000 or any integral multiple of $1,000 in excess thereof. 

(6) The Offered Securities may not be redeemed at the option of the Company prior to the maturity date, except as provided in Article XIV
of the Base Indenture and this Eighth Supplemental Indenture. 
 (7) The Offered Securities will not have the benefit of any
sinking fund. 
 (8) Except as provided herein, the holders of the Offered Securities shall have no special rights in addition
to those provided in the Base Indenture upon the occurrence of any particular events. 
 (9) The Offered Securities will be
general unsecured and unsubordinated obligations of the Company and will be ranked equally among themselves. 
 (10) The Offered
Securities are not convertible into shares of common stock or other securities of the Company. 
 (11) The principal of and the
interest on the Offered Securities shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and private debt. 
 (12) The Offered Securities will be issued as Unrestricted Securities. 
 (13) The
additional redemption provisions, restrictive covenants, Event of Default and defeasance and discharge provisions set forth in Sections 1.3, 1.4, 1.5 and 1.6 shall be applicable to the Offered Securities. 

  
 3 

 Section 1.2. Additional Defined Terms. 

As used herein, the following defined terms shall have the following meanings with respect to the Offered Securities only: 

“Adjusted Redemption Treasury Rate” with respect to any Redemption Date means the rate equal to the semiannual
equivalent yield to maturity or interpolated (on a 30/360 day count basis) yield to maturity of the Comparable Redemption Treasury Issue, assuming a price for the Comparable Redemption Treasury Issue (expressed as a percentage of its principal
amount) equal to the Comparable Redemption Treasury Price for such Redemption Date. 
 “Attributable Debt”, in
connection with a Sale and Lease-Back Transaction, as of any particular time, means the aggregate of present values (discounted at a rate that, at the inception of the lease, represents the effective interest rate that the lessee would have incurred
to borrow over a similar term the funds necessary to purchase the leased assets) of the obligations of the Company or any Restricted Subsidiary for net rental payments during the remaining term of the applicable lease, including any period for which
such lease has been extended or, at the option of the lessor, may be extended. The term “net rental payments” under any lease of any period shall mean the sum of the rental and other payments required to be paid in such period by the
lessee thereunder, not including any amounts required to be paid by such lessee, whether or not designated as rental payments or additional rental payments, on account of maintenance and repairs, reconstruction, insurance, taxes, assessments, water
rates or similar charges required to be paid by such lessee thereunder or any amounts required to be paid by such lessee thereunder contingent upon the amount of sales, maintenance and repairs, reconstruction, insurance, taxes, assessments, water
rates or similar charges. 
 “Below Investment Grade Rating Event” means the Offered Securities are rated below
an Investment Grade Rating by each of the Rating Agencies on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the 60-day period following public notice of the occurrence of the
Change of Control (which 60-day period shall be extended so long as the rating of the Offered Securities is under publicly announced consideration for possible downgrade by any of the Rating Agencies); provided that a Below Investment Grade Rating
Event otherwise arising by virtue of a particular reduction in rating shall be deemed not to have occurred in respect of a particular Change of Control (and thus shall be deemed not to be a Below Investment Grade Rating Event for purposes of the
definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not publicly announce or publicly confirm or inform the Trustee in writing at its request that
the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the
time of the Below Investment Grade Rating Event). 
 “Change of Control” means the occurrence of any of
(1) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the assets of Covidien plc and its
subsidiaries taken as a whole to any person or group of persons for purposes of Section 13(d) of the Exchange Act other than Covidien plc or one of its subsidiaries or a person controlled by Covidien plc or one of its subsidiaries;
(2) consummation of any transaction (including any 

  
 4 

 
merger or consolidation) the result of which is that any “person” (as that term is used in Section 13(d)(3) of the Exchange Act) other than Covidien plc’s or its
subsidiaries’ employee benefit plans, becomes the beneficial owner (as defined in Rules 13(d)(3) and 13(d)(5) under the Exchange Act), directly or indirectly, of more than 50% of the outstanding voting stock of Covidien plc, measured by voting
power rather than number of shares; or (3) the replacement of a majority of the board of directors of Covidien plc over a two-year period from the directors who constituted the board of directors of Covidien plc at the beginning of such period,
and such replacement shall not have been approved by at least a majority of the board of directors of Covidien plc then still in office (either by a specific vote or by approval of a proxy statement in which such member was named as a nominee for
election as a director, without objection to such nomination) who either were members of such board of directors at the beginning of such period or whose election as a member of such board of directors was previously so approved; provided, that, a
transaction effected to create a holding company for Covidien plc will not be deemed to involve a Change of Control if: (1) pursuant to such transaction Covidien plc becomes a direct or indirect wholly-owned subsidiary of such holding company;
(2) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of Covidien plc’s voting stock, if any, immediately prior to that transaction;
and (3) immediately following the transaction no person is the beneficial owner, directly or indirectly, of more than 50% of the voting power represented by the outstanding voting stock of such holding company. Following any such transaction,
references in this definition to Covidien plc shall be deemed to refer to such holding company. For purposes of this definition, “voting stock” of any specified “person” (as that term is used in Section 13(d)(3) of the
Exchange Act) as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person. 
 “Change of Control Triggering Event” means the occurrence of both a Change of Control and a Below Investment Grade Rating Event. 

“Comparable Redemption Treasury Issue” means the United States Treasury security selected by the Quotation Agent as
having a maturity comparable to the remaining term of the Offered Securities to be redeemed that will be utilized at the time of selection and in accordance with customary financial practice in pricing new issues of corporate debt securities of
comparable maturity to the remaining term of such Offered Securities. 
 “Comparable Redemption Treasury Price”
with respect to any Redemption Date means (x) the average of the Redemption Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest such Redemption Reference Treasury Dealer Quotations (unless there
is more than one highest or lowest quotation, in which case only one such highest and/or lowest quotation shall be excluded), or (y) if the Quotation Agent obtains fewer than four such Redemption Reference Treasury Dealer Quotations, the
average of all such Redemption Reference Treasury Dealer Quotations. 
 “Consolidated Net Worth” at any date
means total assets less total liabilities, in each case appearing on the most recently prepared consolidated balance sheet of Covidien plc and its subsidiaries as of the end of a fiscal quarter of Covidien plc, prepared in accordance with GAAP as in
effect on the date of the consolidated balance sheet. 
 “Consolidated Tangible Assets” at any date means total
assets less all intangible assets 

  
 5 

 
appearing on the most recently prepared consolidated balance sheet of Covidien plc and its subsidiaries as of the end of a fiscal quarter of Covidien plc, prepared in accordance with GAAP as in
effect on the date of the consolidated balance sheet. “Intangible assets” means the amount (if any) stated under the heading 
 “Fitch” means Fitch Ratings Ltd. 
 “Funded
Indebtedness” means any Indebtedness maturing by its terms more than one year from the date of the determination thereof, including any Indebtedness renewable or extendible at the option of the obligor to a date later than one year from the
date of the determination thereof. 
 “GAAP” means generally accepted accounting principles set forth in the
FASB Accounting Standards Codification or in such other statements by such other entity as may be approved by a significant segment of the accounting profession of the United States, as in effect from time to time. At any time after the initial date
of issuance of the Offered Securities, the Company may elect (by providing written notice to the Trustee) to apply International Financial Reporting Standards (“IFRS”) in lieu of GAAP and, upon any such election, references herein
to GAAP shall thereafter be construed to mean IFRS (except as otherwise provided herein); provided that any such election, once made, shall be irrevocable. 
 “Goodwill and Other Intangible Assets, Net” or under any other heading of intangible assets separately listed, in each case on the face of such consolidated balance sheet. 

“Indebtedness” means, without duplication, the principal amount (such amount being the face amount or, with respect to
original issue discount bonds or zero coupon notes, bonds or debentures or similar securities, determined based on the accreted amount as of the date of the most recently prepared consolidated balance sheet of Covidien plc and its Subsidiaries as of
the end of a fiscal quarter of Covidien plc prepared in accordance with GAAP as in effect on the date of such consolidated balance sheet) of (i) all obligations for borrowed money, (ii) all obligations evidenced by debentures, notes or
other similar instruments, (iii) all obligations in respect of letters of credit or bankers acceptances or similar instruments or reimbursement obligations with respect thereto (such instruments to constitute Indebtedness only to the extent
that the outstanding reimbursement obligations in respect thereof are collateralized by cash or cash equivalents reflected as assets on a balance sheet prepared in accordance with GAAP), (iv) all obligations to pay the deferred purchase price
of property or services, except (A) trade and similar accounts payable and accrued expenses, (B) employee compensation, deferred compensation and pension obligations, and other obligations arising from employee benefit programs and
agreements or other similar employment arrangements, (C) obligations in respect of customer advances received and (D) obligations in connection with earnout and holdback agreements, in each case in the ordinary course of business,
(v) all obligations as lessee to the extent capitalized in accordance with GAAP and (vi) all Indebtedness of others consolidated in such balance sheet that is guaranteed by the Company or any of its Subsidiaries or for which the Company or
any of its Subsidiaries is legally responsible or liable (whether by agreement to purchase indebtedness of, or to supply funds or to invest in, others). 
 “Investment Grade Rating” means a rating equal to or higher than BBB– (or the equivalent) by Fitch, Baa3 (or the equivalent) by Moody’s and BBB– (or the equivalent) by
S&P. 

  
 6 

 “Moody’s” means Moody’s Investors Service, Inc. 

“Non-Recourse Indebtedness” means Indebtedness upon the enforcement of which recourse may be had by the holder(s)
thereof only to identified assets of Covidien plc, Covidien Ltd. or the Company or any Subsidiary of Covidien plc, Covidien Ltd. or the Company and not to Covidien plc, Covidien Ltd. or the Company or any Subsidiary of Covidien plc, Covidien Ltd. or
the Company personally (subject to, for the avoidance of doubt, customary exceptions contained in non-recourse financings to the non-recourse nature of the obligations thereunder). 

“Principal Property” means any U.S. manufacturing, processing or assembly plant or any U.S. warehouse or distribution
facility of Covidien plc or any of its Subsidiaries that is used by any U.S. Subsidiary of the Company and (A) is owned by Covidien plc or any Subsidiary of Covidien plc on the date hereof, (B) the initial construction of which has been
completed after the date hereof, or (C) is acquired after the date hereof, in each case, other than any such plants, facilities, warehouses or portions thereof, that in the opinion of the Board of Directors of the Company, are not collectively
of material importance to the total business conducted by Covidien plc and its subsidiaries as an entirety, or that has a net book value (excluding any capitalized interest expense), on the date hereof in the case of clause (A) of this
definition, on the date of completion of the initial construction in the case of clause (B) of this definition or on the date of acquisition in the case of clause (C) of this definition, of less than 2.0% of Consolidated Tangible Assets on
the consolidated balance sheet of Covidien plc and its subsidiaries as of the applicable date. 
 “Prospectus”
means the base prospectus dated June 21, 2010, as supplemented by the prospectus supplement dated May 13, 2013. 

“Quotation Agent” means a Redemption Reference Treasury Dealer appointed as such agent by the Company. 

“Rating Agencies” means (1) each of Fitch, Moody’s and S&P; and (2) if any of Fitch, Moody’s or
S&P ceases to rate the Offered Securities or fails to make a rating of such Offered Securities publicly available for reasons outside of the Company’s control, a “nationally recognized statistical rating organization” within the
meaning of Rule 15c3–1(c)(2)(vi)(F) under the Exchange Act, selected by the Company (as certified by a resolution of the Company’s Board of Directors) as a replacement agency for Fitch, Moody’s or S&P, or all of them, as the case
may be. 
 “Redemption Date” shall mean, with respect to any redemption of any Offered Securities, the date
fixed for such redemption pursuant to the terms of the Indenture and such Offered Securities. 
 “Redemption
Price” shall mean, with respect to any redemption of any Offered Securities, the price at which such Offered Securities are to be redeemed as determined pursuant to the terms of the Indenture and Section 1.3 hereof. 

“Redemption Reference Treasury Dealer” means (a) each of Barclays Capital Inc., Merrill Lynch Pierce,
Fenner & Smith Incorporated and Morgan Stanley & Co. LLC or their 

  
 7 

 
affiliates which are primary U.S. government securities dealers, and their respective successors; provided, however, that if any of the foregoing shall cease to be a primary U.S. government
securities dealer (a “Primary Treasury Dealer”), the Company will substitute therefor another Primary Treasury Dealer selected by the Company and (b) any other Primary Treasury Dealer selected by the Company. 

“Redemption Reference Treasury Dealer Quotations” with respect to each Redemption Reference Treasury Dealer and any
Redemption Date means the average, as determined by the Quotation Agent, of the bid and offer prices at 11:00 a.m., New York City time, for the Comparable Redemption Treasury Issue (expressed in each case as a percentage of its principal amount) for
settlement on the Redemption Date quoted in writing to the Quotation Agent by such Redemption Reference Treasury Dealer on the third business day preceding such Redemption Date. 

“Restricted Subsidiary” means any Subsidiary of the Company that owns or leases a Principal Property. 

“Sale and Lease-Back Transaction” means an arrangement with any Person providing for the leasing by the Company or a
Restricted Subsidiary of any Principal Property whereby such Principal Property has been or is to be sold or transferred by the Company or a Restricted Subsidiary to such Person other than Covidien plc, Covidien Ltd., the Company or any of their
respective Subsidiaries; provided, however, that the foregoing shall not apply to any such arrangement involving a lease for a term, including renewal rights, for not more than three years. 

“S&P” means Standard & Poor’s Rating Services, a division of The McGraw-Hill Companies, Inc.

 Section 1.3. Optional Redemption. 
 The Offered Securities will be subject to redemption at the option of the Company on any Redemption Date prior to their maturity date, in whole or from time to time in part, in $1,000 increments
(provided that any remaining principal amount thereof shall be at least the minimum authorized denomination thereof), on not less than 30 nor more than 60 days’ prior notice mailed to the holders of Offered Securities to be redeemed.

 Prior to March 15, 2023, the Offered Securities will be redeemable at a Redemption Price equal to the greater of
(i) 100% of the principal amount of the Offered Securities to be redeemed, and (ii) an amount, as determined by the Quotation Agent and delivered to the Trustee, equal to the sum of the present values of the remaining scheduled payments of
principal and interest thereon due on any date after the Redemption Date (excluding the portion of interest that will be accrued and unpaid to and including the Redemption Date) discounted from their scheduled date of payment to the Redemption Date
(assuming a 360-day year consisting of twelve 30-day months) at the Adjusted Redemption Treasury Rate plus 15 basis points plus, accrued and unpaid interest, if any, to, but excluding, the Redemption Date. 

In addition, the Offered Securities will be redeemable on or after March 15, 2023 at a Redemption Price equal to 100% of the
principal amount of the Offered Securities to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the Redemption Date. 

  
 8 

 Section 1.4. Additional Covenants. 

The following additional covenants shall apply with respect to the Offered Securities so long as any of the Offered Securities remain
Outstanding (but subject to defeasance, as provided in the Indenture): 
 (1) Limitation on Liens. 

The Company will not, and will not permit any Restricted Subsidiary to, issue, assume or guarantee any Indebtedness that is secured by a
mortgage, pledge, security interest, lien or encumbrance (each a “lien”) upon any property that at the time of such issuance, assumption or guarantee constitutes a Principal Property, or any shares of stock of or Indebtedness issued
by any Restricted Subsidiary, whether now owned or hereafter acquired, without effectively providing that, for so long as such lien shall continue in existence with respect to such secured Indebtedness, the Offered Securities (together with, if the
Company shall so determine, any other Indebtedness of the Company ranking equally with the Offered Securities, it being understood that for purposes hereof, Indebtedness which is secured by a lien and Indebtedness which is not so secured shall not,
solely by reason of such lien, be deemed to be of different ranking) shall be equally and ratably secured by a lien ranking ratably with or equal to (or at the Company’s option prior to) such secured Indebtedness; provided, however, that the
foregoing covenant shall not apply to: 
 (a) liens existing on the date the Offered Securities are first issued; 

(b) liens on the stock, assets or Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary, unless
created in contemplation of such Person becoming a Restricted Subsidiary; 
 (c) liens on any assets or Indebtedness of a Person
existing at the time such Person is merged with or into or consolidated with or acquired by the Company or a Restricted Subsidiary or at the time of a purchase, lease or other acquisition of the assets of a corporation or firm as an entirety or
substantially as an entirety by the Company or any Restricted Subsidiary; 
 (d) liens on any Principal Property existing at the
time of acquisition thereof by the Company or any Restricted Subsidiary, or liens to secure the payment of the purchase price of such Principal Property by the Company or any Restricted Subsidiary, or to secure any Indebtedness incurred, assumed or
guaranteed by the Company or a Restricted Subsidiary for the purpose of financing all or any part of the purchase price of such Principal Property or improvements or construction thereon, which Indebtedness is incurred, assumed or guaranteed prior
to, at the time of or within one year after such acquisition (or in the case of real property, completion of such improvement or construction or commencement of full operation of such property, whichever is later); provided, however, that in the
case of any such acquisition, construction or improvement, the lien shall not apply to any Principal Property theretofore owned by the Company or a Restricted Subsidiary, other than the Principal Property so acquired, constructed or improved (and
any accessions thereto and improvements and replacements thereof and the proceeds of the foregoing); 

  
 9 

 (e) liens securing Indebtedness owing by any Restricted Subsidiary to the Company, the
Guarantors or a subsidiary thereof or by the Company to the Guarantors; 
 (f) liens in favor of the United States or any State
thereof, or any department, agency or instrumentality or political subdivision of the United States of America or any State thereof, or in favor of any other country or any political subdivision thereof, to secure partial, progress, advance or other
payments pursuant to any contract, statute, rule or regulation or to secure any Indebtedness incurred or guaranteed for the purpose of financing all or any part of the purchase price (or, in the case of real property, the cost of construction or
improvement) of the Principal Property subject to such liens (including liens incurred in connection with pollution control, industrial revenue or similar financings); 
 (g) pledges, liens or deposits under workers’ compensation or similar legislation, and liens thereunder that are not currently dischargeable, or in connection with bids, tenders, contracts (other
than for the payment of money) or leases to which the Company or any Restricted Subsidiary is a party, or to secure the public or statutory obligations of the Company or any Restricted Subsidiary, or in connection with obtaining or maintaining
self-insurance, or to obtain the benefits of any law, regulation or arrangement pertaining to unemployment insurance, old age pensions, social security or similar matters, or to secure surety, performance, appeal or customs bonds to which the
Company or any Restricted Subsidiary is a party, or in litigation or other proceedings in connection with the matters heretofore referred to in this clause, such as interpleader proceedings, and other similar pledges, liens or deposits made or
incurred in the ordinary course of business; 
 (h) liens created by or resulting from any litigation or other proceeding that
is being contested in good faith by appropriate proceedings, including liens arising out of judgments or awards against the Company or any Restricted Subsidiary with respect to which the Company or such Restricted Subsidiary in good faith is
prosecuting an appeal or proceedings for review or for which the time to make an appeal has not yet expired; or final unappealable judgment liens which are satisfied within 15 days of the date of judgment; or liens incurred by the Company or any
Restricted Subsidiary for the purpose of obtaining a stay or discharge in the course of any litigation or other proceeding to which the Company or such Restricted Subsidiary is a party; 

(i) liens for taxes or assessments or governmental charges or levies not yet due or delinquent; or that can thereafter be paid without
penalty, or that are being contested in good faith by appropriate proceedings; landlords’ liens on property held under lease; and any other liens or charges incidental to the conduct of the business of the Company or any Restricted Subsidiary,
or the ownership of their respective assets, that were not incurred in connection with the borrowing of money or the obtaining of advances or credit and that, in the opinion of the Board of Directors of the Company, do not materially impair the use
of such assets in the operation of the business of the Company or such Restricted Subsidiary or the value of such Principal Property for the purposes of such business; 
 (j) liens to secure the Company’s or any Restricted Subsidiary’s obligations under agreements with respect to spot, forward, future and option transactions, entered into in the ordinary course
of business; 

  
 10 

 (k) liens not permitted by the foregoing clauses (a) to (j), inclusive, if at the time
of, and after giving effect to, the creation or assumption of any such lien, the aggregate amount of all outstanding Indebtedness of the Company and its Restricted Subsidiaries (without duplication) secured by all such liens not so permitted by the
foregoing clauses (a) through (j), inclusive, together with the Attributable Debt in respect of Sale and Lease-Back Transactions permitted by paragraph (a) under subsection (2) below does not exceed the greater of $675,000,000 and 10%
of Consolidated Net Worth; and 
 (l) any extension, renewal or replacement (or successive extensions, renewals or
replacements), in whole or in part, of any lien referred to in the foregoing clauses (a) to (k), inclusive; provided, however, that the principal amount of Indebtedness secured thereby unless otherwise excepted under clauses (a) through
(k) shall not exceed the principal amount of Indebtedness so secured at the time of such extension, renewal or replacement, and that such extension, renewal or replacement shall be limited to all or a part of the assets (or any replacement
assets therefor) that secured the lien so extended, renewed or replaced (plus improvements and construction on real property). 

(2) Limitation on Sale/Leaseback Transactions. 
 The Company will not, and will not permit any Restricted Subsidiary to, enter into any Sale and Lease-Back Transaction unless: 
 (a) the Company or such Restricted Subsidiary, at the time of entering into a Sale and Lease-Back Transaction, would be entitled to incur Indebtedness secured by a lien on the Principal Property to be
leased in an amount at least equal to the Attributable Debt in respect of such Sale and Lease-Back Transaction, without equally and ratably securing the Offered Securities pursuant to subsection (1) above; or 

(b) the direct or indirect proceeds of the sale of the Principal Property to be leased are at least equal to the fair value of such
Principal Property (as determined by the Company’s Board of Directors) and an amount equal to the net proceeds from the sale of the property or assets so leased is applied, within 180 days of the effective date of any such Sale and Lease-Back
Transaction, to the purchase or acquisition (or, in the case of real property, commencement of the construction) of property or assets or to the retirement (other than at maturity or pursuant to a mandatory sinking fund or mandatory redemption
provision) of Securities, or of Funded Indebtedness of the Company or a consolidated Subsidiary ranking on a parity with or senior to the Securities; provided that there shall be credited to the amount of net proceeds required to be applied pursuant
to this clause (b) an amount equal to the sum of (i) the principal amount of Securities delivered within 180 days of the effective date of such Sale and Lease-Back Transaction to the Trustee for retirement and cancellation and
(ii) the principal amount of other Funded Indebtedness voluntarily retired by the Company within such 180-day period, excluding retirements of Securities and other Funded Indebtedness as a result of conversions or pursuant to mandatory sinking
fund or mandatory prepayment provisions. 
 (3) Change of Control Triggering Event. 

(a) Upon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem the Offered
Securities pursuant to Section 1.3 hereof or 

  
 11 

 
Section 14.01 of the Base Indenture, each holder will have the right to require that the Company purchase all or a portion, in $1,000 increments (provided, that any remaining
principal amount thereof shall be at least the minimum authorized denomination thereof), of such holder’s Offered Securities pursuant to Section 1.4(3)(b) hereof (the “Change of Control Offer”), at a repurchase price equal
to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. 

(b) Within 30 days following the date upon which the Change of Control Triggering Event occurred, or at the Company’s option, prior
to any Change of Control, but after the public announcement of the Change of Control, the Company shall send, by first class mail, a notice to each holder, with a copy to the Trustee, which notice shall govern the terms of the Change of Control
Offer. Such notice shall describe the transaction or transactions that constitute the Change of Control and shall state: 
 (A) that the Change of Control Offer is being made pursuant to this Section 1.4(3) of this Eighth Supplemental Indenture; 

(B) that the Company is required to offer to purchase all of the outstanding principal amount of Offered Securities, the
repurchase price and, that on the date specified in such notice, which date shall be no earlier than 30 days and no later than 60 days from the date such notice is mailed, other than as may be required by law (the “Change of
Control Payment Date”), and the Company shall repurchase the Offered Securities validly tendered and not withdrawn pursuant to this Section 1.4(3); 

(C) if mailed prior to the date of consummation of the Change of Control, shall state that the Change of Control Offer is
conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date; 
 (D) that any Offered Security not tendered or accepted for payment shall continue to accrue interest; 
 (E) that, unless the Company defaults in making such payment, Offered Securities accepted for payment pursuant to the Change of Control Offer shall cease to accrue interest after the Change of Control
Payment Date; 
 (F) that holders electing to have an Offered Security purchased pursuant to a Change of Control
Offer may elect to have all or any portion of such Offered Security purchased; 
 (G) that holders of Offered
Securities electing to have Offered Securities purchased pursuant to a Change of Control Offer shall be required to surrender their Offered Securities, with the form entitled “Option of Holder to Elect Purchase” on the reverse of the
Offered Security, or such other customary documents of surrender and transfer as the Company may reasonably request, duly completed, or transfer the Offered Security by book-entry transfer, to the paying agent at the address specified in the notice
prior to the close of business on the third Business Day prior to the Change of Control Payment Date; 

  
 12 

 (H) that holders shall be entitled to withdraw their election if the
Company, the Depositary or the paying agent, as the case may be, receives, not later than the expiration of the Change of Control Offer, a facsimile transmission or letter setting forth the name of the holder, the principal amount of the Offered
Security the holder delivered for purchase and a statement that such holder is withdrawing its election to have such Offered Security purchased; 
 (I) that holders whose Offered Securities are purchased only in part shall be issued new Securities equal in principal amount to the unpurchased portion of the Securities surrendered (or transferred by
book-entry transfer); and 
 (J) the CUSIP number, if any, printed on the Offered Securities being repurchased
and that no representation is made as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Offered Securities. 
 (c) The Company will not be required to make a Change of Control Offer if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for such an offer
made by the Company and such third party purchases all Offered Securities properly tendered and not withdrawn under its offer. 

(d) The Company will comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations
thereunder to the extent such laws and regulations are applicable in connection with the repurchase of Offered Securities pursuant to a Change of Control Offer. To the extent that any securities laws or regulations conflict with the provisions of
this Section 1.4(3), the Company shall comply with the applicable securities laws and regulations and shall be deemed not to have breached its obligations under this Section 1.4(3) by virtue thereof. 

Section 1.5. Additional Event of Default. 
 The following additional event shall be established and shall constitute an “Event of Default” under Section 6.01(a) of the Base Indenture with respect to the Offered Securities so long as
any of the Offered Securities remain Outstanding: 
 (9) an event of default shall occur and be continuing with respect to the Company’s or
any Guarantor’s Indebtedness for borrowed money (other than Non-Recourse Indebtedness) under any indenture or other instrument evidencing or under which the Company or any Guarantor shall have a principal amount outstanding (such amount with
respect to original issue discount bonds or zero coupon notes, bonds or debentures or similar securities based on the accreted amount determined in accordance with GAAP and as of the date of the most recently prepared consolidated balance sheet of
the Company or any Guarantor, as the case may be) in excess of $100,000,000, and such event of default shall involve the failure to pay the principal of such Indebtedness on the final maturity date thereof after the expiration of any applicable
grace period with respect thereto, or such Indebtedness shall have been accelerated so that the same shall have become due and payable prior to the date on which the same would otherwise have become due and payable, and such acceleration shall not
be rescinded or annulled within ten Business Days 

  
 13 

 
after notice thereof shall have been given to the Company and the Guarantors by the Trustee, or to the Company, the Guarantors and the Trustee by the holders of at least 25% in aggregate
principal amount of the Outstanding Securities of all series affected thereby; provided that, if such event of default under such indenture or instrument shall be remedied or cured by the Company or such Guarantor or waived by the requisite holders
of such Indebtedness, then the Event of Default hereunder by reason thereof shall be deemed likewise to have been thereupon remedied, cured or waived without further action upon the part of either the Trustee or any of the holders, and provided
further, however, that subject to the provisions of Sections 7.01 and 7.02, the Trustee shall not be charged with knowledge of any such event of default unless written notice thereof shall have been given to the Trustee by the Company or any
Guarantor, as the case may be, by the holder or an agent of the holder of any such Indebtedness, by the trustee then acting under any indenture or other instrument under which such event of default shall have occurred, or by the holders of not less
than 25% in the aggregate principal amount of Outstanding Securities of all series affected thereby. 
 Section 1.6. Defeasance and
Discharge of Obligations 
 With respect to a redemption of all of the Offered Securities pursuant to Section 1.3
hereof, notwithstanding the provisions of Section 11.03(c) of the Base Indenture, for purposes of determining whether the Company has satisfied the condition set forth in clause (i) of such Section 11.03(c), the amount of funds or
Governmental Obligations that the Company must irrevocably deposit or cause to be deposited in trust with the Trustee shall be determined using an assumed Redemption Price calculated as of the date of deposit of such funds or Governmental
Obligations in trust (and not, for the avoidance of doubt, the Redemption Date); provided that: 
 (a) at the
time of deposit of such funds or Governmental Obligations in trust, the funds or Governmental Obligations in trust must be sufficient, as evidenced by a certificate of a reputable firm of certified independent accountants, investment bank or
appraisal firm, to pay and discharge the principal, premium, if any, and accrued and unpaid interest on the Offered Securities on the Redemption Date with an assumed Redemption Price calculated as of the date of deposit of such funds or Governmental
Obligations in trust; and 
 (b) the Company must irrevocably deposit or cause to be deposited additional funds
or Governmental Obligations in trust, as necessary, on the Redemption Date, as required by Section 1.3 hereof, necessary to pay the Redemption Price as determined on such date. 

ARTICLE II 

MISCELLANEOUS 

Section 2.1. Definitions. 
 Capitalized terms used but not defined in this Eighth Supplemental Indenture shall have the meanings ascribed thereto in the Base Indenture. 

  
 14 

 Section 2.2. Confirmation of Indenture. 

The Base Indenture, as supplemented and amended by this Eighth Supplemental Indenture, is in all respects ratified and confirmed, and the
Base Indenture, this Eighth Supplemental Indenture and all indentures supplemental thereto shall be read, taken and construed as one and the same instrument. 
 Section 2.3. Concerning the Trustee. 
 In carrying out the
Trustee’s responsibilities hereunder, the Trustee shall have all of the rights, protections and immunities, including without limitation the right to indemnification, which it possesses under the Indenture. The recitals contained herein and in
the Offered Securities, except the Trustee’s certificate of authentication, shall be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to
(i) the validity or sufficiency of this Eighth Supplemental Indenture or of the Offered Securities, (ii) the proper authorization hereby by the Company or the Guarantors by action or otherwise, (iii) the due execution hereof by the
Company or the Guarantors or (iv) the consequences of any amendment herein provided for. The Trustee shall not be accountable for the use or application by the Company of the Offered Securities or the proceeds thereof. 

Section 2.4. Governing Law. 
 This Eighth Supplemental Indenture and the Offered Securities shall be deemed to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance
with the laws of said State without regard to conflicts of laws principles that would require the application of any other law. 

Section 2.5. Separability. 
 In case any provision in this Eighth Supplemental Indenture shall for any reason be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions
shall not in any way be affected or impaired thereby. 
 Section 2.6. Counterparts. 

This Eighth Supplemental Indenture may be executed in any number of counterparts each of which shall be an original, but such counterparts
shall together constitute but one and the same instrument. 
 Section 2.7 No Benefit. 

Nothing in this Eighth Supplemental Indenture, express or implied, shall give to any Person other than the parties hereto and their
successors or assigns, and the holders of the Offered Securities, any benefit or legal or equitable rights, remedy or claim under this Eighth Supplemental Indenture or the Base Indenture. 
 Section 2.8 Additional Debt Securities. 
 In accordance with
Section 2.01 of the Base Indenture, the Company may from time to time, without giving notice to or seeking the consent of the holders of any series of notes, issue 

  
 15 

 
debt securities having the same ranking and the same interest rate, maturity and other terms (except for the issue date, the public offering price and the first interest payment date) as, and
ranking equally and ratably with the Offered Securities. Any additional Securities having such similar terms, together with the Offered Securities, will constitute a single series of Securities under the Indenture, including for purposes of voting
and redemptions; provided that if the additional Securities are not fungible with the Offered Securities for U.S. federal income tax purposes, the additional Securities will have a separate CUSIP number. No such additional Securities may be issued
if an Event of Default has occurred and is continuing with respect to the Offered Securities. 

  
 16 

 IN WITNESS WHEREOF, the parties hereto have caused this Eighth Supplemental Indenture to be
duly executed all as of the day and year first above written. 
  

			
	
	COVIDIEN INTERNATIONAL FINANCE S.A.
		
	By:	 	 /s/ Michelangelo Stefani

	Name:	 	Michelangelo Stefani
	Title:	 	Managing Director
	
	COVIDIEN PUBLIC LIMITED COMPANY
		
	By:	 	 /s/ Charles J. Dockendorff

	Name:	 	Charles J. Dockendorff
	Title:	 	Executive Vice President and Chief Financial Officer
	
	COVIDIEN LTD.
		
	By:	 	 /s/ Charles J. Dockendorff

	Name:	 	Charles J. Dockendorff
	Title:	 	Executive Vice President and Chief Financial Officer
	
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee
		
	By:	 	 /s/ Carol Ng

	Name:	 	Carol Ng
	Title:	 	Vice President
		
	By:	 	 /s/ Nigel W. Luke

	Name:	 	Nigel W. Luke
	Title:	 	Vice President

 [Signature Page to Eighth Supplemental Indenture] 

 EXHIBIT A 
 FORM OF 2023 NOTES 
 THIS GLOBAL SECURITY IS HELD BY THE DEPOSITARY (AS
DEFINED IN THE INDENTURE GOVERNING THIS SECURITY) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (I) THE TRUSTEE MAY MAKE ANY SUCH NOTATIONS
HEREON AS MAY BE REQUIRED PURSUANT TO THE INDENTURE, (II) THIS GLOBAL SECURITY MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.05(C) OF THE INDENTURE, (III) THIS GLOBAL SECURITY MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION
PURSUANT TO THE INDENTURE AND (IV) THIS GLOBAL SECURITY MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF THE COMPANY. 
 UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A
NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR TO ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF ANY ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY
(AND ANY PAYMENT IS MADE TO SUCH ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF
HAS AN INTEREST HEREIN. 
 2.950% SENIOR NOTES DUE 2023 

 

			
	No. [    ]	  	$[        ]

 CUSIP No. 22303Q AP5 
 COVIDIEN INTERNATIONAL FINANCE S.A. 
 promises to pay to Cede & Co. or registered
assigns, the principal sum as set forth in the Schedule of Exchanges of Notes attached hereto on June 15, 2023. 
  

			
	Interest Payment Dates:	  	June 15 and December 15
		
	Record Dates:	  	June 1 and December 1

 Each holder of this Security (as defined below), by accepting the same, agrees to and shall be bound by
the provisions hereof and of the Indenture described herein, and authorizes and directs the Trustee described herein on such holder’s behalf to be bound by such provisions. Each holder of this Security hereby waives all notice of the acceptance
of the provisions contained herein and in the Indenture and waives reliance by such holder upon said provisions. 
 This
Security shall not be entitled to any benefit under the Indenture, or be valid or become obligatory for any purpose, until the Certificate of Authentication hereon shall have been signed by or on behalf of the Trustee. The provisions of this
Security are continued on the reverse side hereof, and such continued provisions shall for all purposes have the same effect as though fully set forth at this place. 

 IN WITNESS WHEREOF, the Company has caused this instrument to be signed in accordance with Section 2.04
of the Indenture. 
  

			
	COVIDIEN INTERNATIONAL FINANCE S.A.
	
	  

	Name:	 	Michelangelo Stefani
	Title:	 	Managing Director

 Dated: May 16, 2013 
 CERTIFICATE OF AUTHENTICATION 
 This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture. 
  

			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee
		
	By:	 	  

		 	Authorized Signatory
		
	By:	 	  

		 	Authorized Signatory
	
	Dated: May 16, 2013

 GUARANTEE 
 For value received, Covidien public limited company and Covidien Ltd., jointly and severally, hereby absolutely, unconditionally and irrevocably guarantee to the holder of the Security upon which this
Guarantee is set forth, the payment of principal of, premium, if any, and interest on, such Security in the amounts and at the time when due and payable whether by declaration thereof or otherwise, and interest on the overdue principal and interest,
if any, of such Security, if lawful, to the holder of such Security and the Trustee on behalf of the holders, all in accordance with and subject to the terms and limitations of such Security and Article XV of the Indenture. This Guarantee will not
become effective until the Trustee or Authenticating Agent duly executes the certificate of authentication on the Security upon which this Guarantee is set forth. This Guarantee shall be governed by and construed in accordance with the laws of the
State of New York, without regard to conflict of law principles thereof. 
 Dated: May 16, 2013 

GIVEN under the Company Seal 
 of COVIDIEN
PUBLIC LIMITED COMPANY 
 in the presence of: 

 

			
	By:	 	  

	Name:	 	Charles J. Dockendorff
	Title:	 	 Executive Vice President and

Chief Financial Officer

  

			
	COVIDIEN LTD.
		
	By:	 	  

	Name:	 	Charles J. Dockendorff
	Title:	 	 Executive Vice President and

Chief Financial Officer

 [REVERSE OF NOTE] 

Covidien International Finance S.A. 
 2.950% Senior Notes due 2023 
 This security is one of a duly authorized series of debt
securities of Covidien International Finance S.A., a Luxembourg company (the “Company”), issued or to be issued in one or more series under and pursuant to an Indenture for the Company’s unsubordinated debt securities, dated as
of October 22, 2007 (as supplemented prior to the date of the Eighth Supplemental Indenture (as defined below), the “Base Indenture”), duly executed and delivered by and among the Company, Covidien public limited company
(“Covidien plc”), Covidien Ltd. (“Covidien Ltd.,” and together with Covidien plc, the “Guarantors”) and Deutsche Bank Trust Company Americas (the “Trustee”), as supplemented by the
Eighth Supplemental Indenture, dated as of May 16, 2013 (the “Eighth Supplemental Indenture”), by and among the Company, the Guarantors and the Trustee. The Base Indenture as supplemented by the Eighth Supplemental Indenture is
referred to herein as the “Indenture.” By the terms of the Base Indenture, the debt securities issuable thereunder are issuable in series that may vary as to amount, date of maturity, rate of interest and in other respects as
provided in the Base Indenture. This security is one of the series designated on the face hereof (individually, a “Security,” and collectively, the “Securities”), and reference is hereby made to the Indenture for a
description of the rights, limitations of rights, obligations, duties and immunities of the Trustee, the Company, the Guarantors and the holders of the Securities (the “Securityholders”). Capitalized terms used herein and not
otherwise defined shall have the meanings given them in the Base Indenture or the Eighth Supplemental Indenture, as applicable. 

1. Interest. The Company promises to pay interest on the principal amount of this Security at an annual rate of 2.950%. The
Company will pay interest semi-annually on June 15 and December 15 of each year (each such day, an “Interest Payment Date”). If any Interest Payment Date, redemption date or maturity date of this Security is not a Business
Day, then payment of interest or principal (and premium, if any) shall be made on the next succeeding Business Day with the same force and effect as if made on the date such payment was due, and no interest shall accrue for the period after such
date to the date of such payment on the next succeeding Business Day. Interest on the Securities will accrue from the most recent date to which interest has been paid or duly provided for or, if no interest has been paid, from the date of issuance;
provided that, if there is no existing Default in the payment of interest, and if this Security is authenticated between a regular record date referred to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue
from such next succeeding Interest Payment Date; and provided, further, that the first Interest Payment Date shall be December 15, 2013. Interest will be calculated on the basis of a 360-day year of twelve 30-day months. In
certain circumstances, liquidated damages may be payable as provided in Section 6.01 of the Indenture. Any such liquidated damages shall be payable in the same manner and on the same dates as the stated interest payable on this Security.

 2. Method of Payment. The Company will pay interest on the Securities (except defaulted interest), if any,
to the persons in whose name such Securities are registered at the close of business on the regular record date referred to on the facing page of this Security for such interest installment. In the event that the Securities or a portion thereof are
called for redemption 

 
and the Redemption Date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Securities will be paid upon
presentation and surrender of such Securities as provided in the Indenture. The principal of and the interest on the Securities shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and
private debt, at the office or agency of the Company maintained for that purpose in accordance with the Indenture. 

3. Paying Agent and Registrar. Initially, Deutsche Bank Trust Company Americas, the Trustee, will act as paying agent
and Security Registrar. The Company may change or appoint any paying agent or Security Registrar without notice to any Securityholder. The Company, the Guarantors or any of their Subsidiaries may act in any such capacity. 

4. Indenture. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by
reference to the Trust Indenture Act of 1939 (“TIA”) as in effect on the date the Indenture is qualified. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and TIA for a statement of
such terms. The Securities are unsecured general obligations of the Company and constitute the series designated on the face hereof as the “2.950% Senior Notes due 2023”, initially limited to $750,000,000 in aggregate principal amount. The
Company will furnish to any Securityholder upon written request and without charge a copy of the Base Indenture and the Eighth Supplemental Indenture. Requests may be made to: Covidien International Finance S.A., 4th Floor, 3b bd Prince Henri,
L-1724 Luxembourg, Attention: The Managing Directors. 
 5. Optional Redemption. The Securities will be subject
to redemption at the option of the Company on any date prior to their maturity date, in whole or from time to time in part, in $1,000 increments (provided that any remaining principal amount thereof shall be at least the minimum authorized
denomination thereof), on written notice, sent by first class mail, to the Securityholders thereof not less than 30 days nor more than 60 days prior to the date fixed for redemption in such notice (the “Redemption Date”).

 Prior to March 15, 2023, the Securities will be redeemable at a Redemption Price equal to the greater of (i) 100%
of the principal amount of the Securities to be redeemed, and (ii) an amount, as determined by the Quotation Agent and delivered to the Trustee, equal to the sum of the present values of the remaining scheduled payments of principal and
interest thereon due on any date after the Redemption Date (excluding the portion of interest that will be accrued and unpaid to and including the Redemption Date) discounted from their scheduled date of payment to the Redemption Date (assuming a
360-day year consisting of twelve 30-day months) at the Adjusted Redemption Treasury Rate, plus 15 basis points, plus accrued and unpaid interest, if any, to, but excluding, the Redemption Date. 

In addition, the Securities will be redeemable on or after March 15, 2023 at a Redemption Price equal to 100% of the principal
amount of the Securities to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the Redemption Date. 
 The Securities are also subject to redemption to the extent provided in Article XIV of the Indenture. 
 If the giving of the notice of redemption is completed as provided in the Indenture, interest on such Securities or portions of Securities shall cease to accrue on and after the Redemption Date, unless
the Company shall default in the payment of such Redemption Price and accrued interest with respect to any such Security or portion thereof. 

 The Company shall not be required to make mandatory redemption or sinking fund payments with
respect to the Securities. 
 6. Change of Control Triggering Event. Upon the occurrence of a Change of Control
Triggering Event, unless the Company has exercised its right to redeem this Security, the Securityholder of this Security will have the right to require that the Company purchase all or a portion, in $1,000 increments (provided that any
remaining principal amount thereof shall be at least the minimum authorized denomination thereof), of this Security at a repurchase price equal to 101% of the principal amount hereof, plus accrued and unpaid interest, if any, to, but
excluding, the repurchase date. Within 30 days following the date upon which the Change of Control Triggering Event occurred, or at the Company’s option, prior to any Change of Control, but after the public announcement of the Change of
Control, the Company shall send, by first class mail, a notice to each Securityholder, with a copy to the Trustee, which notice shall govern the terms of the Change of Control Offer. 

7. Denominations, Transfer, Exchange. The Securities are in registered form without coupons in the denominations of
$2,000 or any integral multiple of $1,000 in excess thereof. The transfer of Securities may be registered and Securities may be exchanged as provided in the Indenture. The Securities may be presented for exchange or for registration of transfer
(duly endorsed or with the form of transfer endorsed thereon duly executed if so required by the Company or the Security Registrar) at the office of the Security Registrar or at the office of any transfer agent designated by the Company for such
purpose. No service charge will be made for any registration of transfer or exchange, but a Securityholder may be required to pay any applicable taxes or other governmental charges. If the Securities are to be redeemed, the Company will not be
required to: (i) issue, register the transfer of, or exchange any Securities during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of less than all of the Outstanding Securities and
ending at the close of business on the day of such mailing; (ii) register the transfer of or exchange any Securities or portions thereof selected for redemption, in whole or in part, except the unredeemed portion of any such Security being
redeemed in part; nor (iii) register the transfer of or exchange a Security between the applicable record date and the next succeeding Interest Payment Date. 
 8. Persons Deemed Owners. The registered Securityholder shall be treated as its owner for all purposes. 
 9. Repayment to the Guarantors or the Company. Any funds or Governmental Obligations deposited with any paying agent or the Trustee, or then held by the Guarantors or the Company, in trust for
payment of principal of, premium, if any, or interest on the Securities that are not applied but remain unclaimed by the Securityholders for at least one year after the date upon which the principal of, premium, if any, or interest on the Securities
shall have respectively become due and payable, shall be repaid to the Guarantors or the Company, as applicable, or (if then held by the Guarantors or the Company) shall be discharged from such trust. After return to the Company or the Guarantors,
Securityholders entitled to the money or securities must look to the Company or the Guarantors, as applicable, for payment as unsecured general creditors. 

 10. Amendments, Supplements and Waivers. The Base Indenture contains
provisions permitting the Company, the Guarantors and the Trustee, with the consent of the Securityholders of not less than a majority in aggregate principal amount of the Outstanding Securities to enter into supplemental indentures for the purpose
of adding, changing or eliminating any provisions to the Base Indenture or supplemental indenture or indentures or of modifying in any manner not covered elsewhere in the Base Indenture the rights of the Securityholders; provided,
however, that no such supplemental indenture, without the consent of the Securityholders of each Note then Outstanding and affected thereby, shall: (i) extend a fixed maturity of or any installment of principal of the Securities or
reduce the principal amount thereof, or reduce the amount of principal of any original issue discount security that would be due and payable upon declaration of acceleration of the maturity thereof; (ii) reduce the rate of or extend the time
for payment of interest of the Securities; (iii) reduce the premium payable upon the redemption of the Securities; (iv) make any Security payable in Currency other than that stated in the Securities; (v) impair the right to institute
suit for the enforcement of any payment on or after the fixed maturity thereof (or in the case or redemption, on or after the redemption date); or (vi) reduce the percentage of the Securities, the Securityholders of which are required to
consent to any such supplemental indenture or indentures. The Base Indenture also contains provisions permitting the Securityholders of not less than a majority in aggregate principal amount of the Outstanding Securities, on behalf of all of the
Securityholders, to waive any past Default under the Base Indenture, and its consequences, except a Default in the payment of the principal of, premium, if any, or interest on any Security or a Default in respect of a covenant or provision of the
Base Indenture that cannot be modified or amended without the consent of the holder of each Outstanding Security. Any such consent or waiver by the registered Securityholder shall be conclusive and binding upon such Securityholder and upon all
future Securityholders and owners of this Security and of any Securities issued in exchange for this Security or in place hereof (whether by registration of transfer or otherwise), irrespective of whether or not any notation of such consent or
waiver is made upon this Security. 
 11. Defaults and Remedies. If an Event of Default with respect to the
Securities occurs and is continuing, the Trustee or the Securityholders of at least 25% in aggregate principal amount of the Securities then Outstanding, by notice in writing to the Company and the Guarantors (and to the Trustee if notice is given
by such Securityholders), may declare the unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately. Subject to the terms of the Indenture, if an Event of Default under the Indenture shall occur and be
continuing, the Trustee will be under no obligation to exercise any of its rights or powers under the Indenture at the request or direction of any of the Securityholders, unless such Securityholders have offered the Trustee indemnity satisfactory to
it. Upon satisfaction of certain conditions set forth in the Indenture, the Securityholders of a majority in principal amount of the Outstanding Securities will have the right to direct the time, method and place of conducting any proceeding for any
remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the Securities. 

12. Trustee, Paying Agent and Security Registrar May Hold Securities. The Trustee, subject to certain limitations imposed by the
TIA, or any paying agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not Trustee, paying agent or Security Registrar. 

 13. No Recourse Against Others. No recourse under or upon any obligation,
covenant or agreement of the Indenture, or of any Security, or for any claim based thereon or otherwise in respect hereof or thereof, shall be had against any incorporator, stockholder, officer or director, past, present or future as such, of the
Guarantors or the Company or of any predecessor or successor corporation, either directly or through the Guarantors or the Company or any such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by
the enforcement of any assessment or penalty or otherwise; it being expressly understood that the Indenture and the obligations issued hereunder and thereunder are solely corporate obligations, and that no such personal liability whatever shall
attach to, or is or shall be incurred by, the incorporators, shareholders, officers or directors as such, of the Guarantors or the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness
authorized by the Indenture, or under or by reason of the obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom; and that any and all such personal liability of every name and nature, either at
common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, shareholder, officer or director as such, because of the creation of the indebtedness authorized by the Indenture, or
under or by reason of the obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the acceptance of the
Securities. 
 14. Discharge of Indenture. The Indenture contains certain provisions pertaining to defeasance,
which provisions shall for all purposes have the same effect as if set forth herein. 

15. Authentication. This Security shall not be valid until the Trustee signs the certificate of authentication attached
to the other side of this Security. 
 16. Guarantees. All payments by the Company under the Indenture and this Note are
fully and unconditionally guaranteed to the Securityholder of this Security, jointly and severally, by the Guarantors, as provided in the related Guarantee and the Indenture. 
 17. Additional Amounts. The Company and the Guarantors are obligated to pay Additional Amounts on this Note to the extent provided in Article XIV of the Indenture. 

18. Abbreviations. Customary abbreviations may be used in the name of a Securityholder or an assignee, such as: TEN COM
(= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

19. Governing Law. The Base Indenture, the Eighth Supplemental Indenture and this Security (and the Guarantee hereon)
shall be deemed to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said State. 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: (I) or (we) assign and transfer this Security to 

 
  
 (Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
 (Print or type assignee’s name,
address and zip code) 
  

			
	and irrevocably appoint	 	  

	agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.

 Date:
                     

Your Signature:
                                         
                            
 (Sign exactly as your name appears on the face of this Security) 
 Signature Guarantee:
                                         
                    

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Security purchased by the Company pursuant to Section 1.4(3) of the Eighth Supplemental Indenture,
check the box: 
  

	 ̈	1.4(3) Change of Control Triggering Event 

 If you want to elect to have only part of this Security purchased by the Company pursuant to Section 1.4(3) of the Eighth Supplemental Indenture, state the amount:
$        . 
  

					
	Date:                     	 		 	Your Signature:
                                         
                                   
		 		 	(Sign exactly as your name appears on the other side of the Security)

 Tax I.D. number 
  

			
	 Signature Guarantee:
	 	  

		 	(Signature must be guaranteed by a participant in a recognized signature guarantee medallion program)

 SCHEDULE OF EXCHANGES OF NOTES 

The following exchanges of a part of this Global Note for Definitive Notes or a part of another Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of decrease

in principal amount
 of this Global Note
	 	 Amount of increase

in principal amount
 of this Global Note
	 	 Principal amount of

this Global Note
 following such
 decrease (or

increase)
	 	 Signature of

authorized signatory of
Trustee or Securities
Custodian

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}]]